Clinical trial
A Randomized Controlled Trial Using Endoscopic Brush Cytology and Single Cell Clonal Dynamics of Early ESOPHAGEAL ADENOCARCINOMA for Assessing Effects on Quality of Life, Cancer Worry and Defining Cost-Effective Surveillance Strategies
NCT07455422 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial Using Endoscopic Brush Cytology and Single Cell Clonal Dynamics of Early ESOPHAGEAL ADENOCARCINOMA for Assessing Effects on Quality of Life, Cancer Worry and Defining Cost-Effective Surveillance Strategies
- Lead sponsor
- University Hospital, Antwerp
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 1, 2026
- Completion date
- December 31, 2030
- Enrollment
- 266 (estimated)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
adenocarcinoma - gej, barrett esophagus, barrett esophagus adenocarcinoma, gastroenterological cancer, gastroenterology